SCHEMBL23258752

SCHEMBL23258752

c1ccc(-c2ccc(-c3ccc(N(c4ccc(-c5cc6ccccc6c6ccccc56)cc4)c4cccc5sc6ccccc6c45)cc3)cc2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.35
ALDH1A1 P00352 3/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
HPGD P15428 2/20 0.35
KDM4E B2RXH2 2/20 0.35
MAPT P10636 2/20 0.35
MPI P34949 1/20 0.35
GPR84 Q9NQS5 3/20 0.34
MAPK1 P28482 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
TSHR P16473 1/20 0.33
CASP1 P29466 1/20 0.33
HIF1A Q16665 1/20 0.33
HSD17B10 Q99714 1/20 0.33
F9 P00740 1/20 0.32
HSD17B1 P14061 1/20 0.31
HSD17B2 P37059 1/20 0.31
GPR3 P46089 1/20 0.30
USP2 O75604 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23258158 1.00 CYP11B1 (0.35) CYP11B1ALDH1A1MEN1KMT2AHPGD
SCHEMBL23258075 1.00 CYP11B1 (0.35) CYP11B1ALDH1A1MEN1KMT2AHPGD
SCHEMBL23258751 0.98 CYP11B1 (0.34) CYP11B1ALDH1A1MEN1KMT2AHPGD
SCHEMBL22255684 0.96 CYP11B1 (0.35) CYP11B1ALDH1A1MEN1KMT2AHPGD
SCHEMBL23258051 0.96 ALDH1A1 (0.35) CYP11B1ALDH1A1MEN1KMT2AHPGD
SCHEMBL23258753 0.96 ALDH1A1 (0.36) CYP11B1ALDH1A1MEN1KMT2AHPGD
SCHEMBL23258160 0.96 CYP11B1 (0.33) CYP11B1ALDH1A1MEN1KMT2AHPGD
SCHEMBL22255342 0.96 HSD17B1 (0.33) CYP11B1ALDH1A1MEN1KMT2AHPGD
SCHEMBL22255386 0.96 ALDH1A1 (0.35) CYP11B1ALDH1A1MEN1KMT2AHPGD
SCHEMBL22255765 0.94 HSD17B1 (0.33) CYP11B1ALDH1A1MEN1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210119135-A1 LUMINESCENCE DEVICE AND AMINE COMPOUND FOR LUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2021-04-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210119135-A1 LUMINESCENCE DEVICE AND AMINE COMPOUND FOR LUMINESCENCE DEVICE SLC18A1, SLC29A1, SAT1 CYP11B1 1814/4885ALDH1A1 71/4885MEN1 1017/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.